Genomic structure and identification of novel mutations in Usherin, the gene responsible for Usher syndrome type IIa

被引:148
|
作者
Weston, MD
Eudy, JD
Fujita, S
Yao, SF
Usami, S
Cremers, C
Greenburg, J
Ramesar, R
Martini, A
Moller, C
Smith, RJ
Sumegi, J
Kimberling, WJ
机构
[1] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA
[2] Univ Nebraska, Med Ctr, Monroe Meyer Inst Genet & Rehabil, Ctr Genet Mol, Omaha, NE USA
[3] Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 036, Japan
[4] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan
[5] Katholieke Univ Nijmegen, Nijmegen, Netherlands
[6] Univ Cape Town, Sch Med, Dept Genet, ZA-7925 Cape Town, South Africa
[7] Univ Ferrara, ENT Dept, I-44100 Ferrara, Italy
[8] Univ Gothenburg, Dept Audiol, Gothenburg, Sweden
[9] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA
关键词
D O I
10.1086/302855
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Usher syndrome type IIa (USHIIa) is an autosomal recessive disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pigmentosa, This disorder maps to human chromosome 1q41. Recently, mutations in USHIIa patients were identified in a novel gene isolated from this chromosomal region. The USH2A gene encodes a protein with a predicted molecular weight of 171.5 kD and possesses laminin epidermal growth factor as well as fibronectin type III domains. These domains are observed in other protein components of the basal lamina and extracellular matrixes; they may also be observed in cell-adhesion molecules. The intron/exon organization of the gene whose protein we name "Usherin" was determined by direct sequencing of PCR products and cloned genomic DNA with cDNA-specific primers. The gene is encoded by 21 exons and spans a minimum of 105 kb. A mutation search of 57 independent USHIIa probands was performed with a combination of direct sequencing and heteroduplex analysis of PCR-amplified exons. Fifteen new mutations were found. Of 114 independent USH2A alleles, 58 harbored probable pathologic mutations. Ten cases of USHIIa were true homozygotes and 10 were compound heterozygotes; 18 heterozygotes with only one identifiable mutation were observed. Sixty-five percent (38/58) of cases had at least one mutation, and 51% (58/114) of the total number of possible mutations were identified. The allele 2299delG (previously reported as 2314delG) was the most frequent mutant allele observed (16%; 31/192). Three new missense mutations (C319Y, N346H, and C419F) were discovered; all were restricted to the previously unreported laminin domain VI region of Usherin. The possible significance of this domain, known to be necessary for laminin network assembly, is discussed in the context of domain VI mutations from other proteins.
引用
收藏
页码:1199 / 1210
页数:12
相关论文
共 50 条
  • [31] Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D
    von Brederlow, B
    Bolz, H
    Janecke, A
    Cabrera, AL
    Rudolph, G
    Lorenz, B
    Schwinger, E
    Gal, A
    HUMAN MUTATION, 2002, 19 (03) : 268 - 273
  • [32] Identification of Novel USH2A Mutations in a Consanguineous Chinese Family With Usher Syndrome
    Wang, Haolin
    Wei, Bo
    Guo, Jiaxin
    Wu, Xiawei
    Zou, Tongdan
    Wang, Ting
    Zhang, Tiantian
    Gong, Bo
    Hao, Jilong
    Zhang, Houbin
    Wang, Le
    HUMAN MUTATION, 2025, 2025 (01)
  • [33] A mutation (2314delG) in the usher syndrome type IIA gene: High prevalence and phenotypic variation
    Liu, XZ
    Hope, C
    Liang, CY
    Zou, JM
    Xu, LR
    Cole, T
    Mueller, RF
    Bundey, S
    Nance, W
    Steel, KP
    Brown, SDM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) : 1221 - 1225
  • [34] Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II
    Aller, E.
    Jaijo, T.
    Beneyto, M.
    Najera, C.
    Oltra, S.
    Ayuso, C.
    Baiget, M.
    Carballo, M.
    Antinolo, G.
    Valverde, D.
    Moreno, F.
    Vilela, C.
    Collado, D.
    Perez-Garrigues, H.
    Navea, A.
    Millan, J. M.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 (11) : e55
  • [35] Identification of novel USH2A mutations in a consanguineous Chinese family with Usher syndrome
    Zhang, Houbin
    Wang, Haolin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [36] Identification of a Novel CLRN1 Gene Mutation in Usher Syndrome Type 3: Two Case Reports
    Yoshimura, Hidekane
    Oshikawa, Chie
    Nakayama, Jun
    Moteki, Hideaki
    Usami, Shin-ichi
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2015, 124 : 94S - 99S
  • [37] Identification of two novel mutations in the CACNA1A gene responsible for episodic ataxia type 2
    Scoggan, KA
    Chandra, T
    Nelson, R
    Hahn, AF
    Bulman, DE
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (04) : 249 - 253
  • [38] Two novel disease-causing mutations in the CLRN1 gene in patients with Usher syndrome type 3
    Garcia-Garcia, Gema
    Aparisi, Mara J.
    Rodrigo, Regina
    Sequedo, Maria D.
    Espinos, Carmen
    Rosell, Jordi
    Olea, Jose L.
    Paz Mendvil, M.
    Ramos-Arroyo, Maria A.
    Ayuso, Carmen
    Jaijo, Teresa
    Aller, Elena
    Millan, Jose M.
    MOLECULAR VISION, 2012, 18 (314-15): : 3070 - 3078
  • [39] Identification of five novel mutations responsible for type 1 antithrombin deficiency
    Jochmans, K
    Lissens, W
    Peerlinck, K
    Seghers, J
    Stibbe, J
    vandeLoo, J
    DeWaele, M
    Liebaers, I
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1762 - P1762
  • [40] Identification of a novel MYO7A mutation in Usher syndrome type 1
    Cheng, Ling
    Yu, Hongsong
    Jiang, Yan
    He, Juan
    Pu, Sisi
    Li, Xin
    Zhang, Li
    ONCOTARGET, 2018, 9 (02) : 2295 - 2303